To demonstrate whether exogenous cholesterol alters cell proliferation in triple-negative breast cancer patient-derived xenograft (TNBC-PDX) cells in an ERRα-dependent manner, these cells were treated with vehicle, cholesterol, and/or Compound 29 (cpd29), a selective inverse agonist of ERRα [32]. Here, ESRRA is linked to triple-negative breast carcinoma.